Determination of Beta-Blockers in Urine Using SFC/MS

Article

LCGC North America

This Application Note demonstrates the separation and quantification of beta-blockers, listed as prohibited substances by the World Anti-Doping Agency, in urine using the Agilent 1260 Infinity Analytical SFC System.

 

Related Content